• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰患者对其哮喘的了解和管理情况如何?一项社区研究。

How well do New Zealand patients understand and manage their asthma? A community study.

作者信息

Sinclair B L, Clark D W, Sears M R

机构信息

Department of Pharmacology, University of Otago Medical School, Dunedin.

出版信息

N Z Med J. 1987 Nov 11;100(835):674-7.

PMID:3452148
Abstract

Patient understanding of the nature of asthma and of its management was assessed using an interviewer administered questionnaire in a community sample of asthmatics identified through prescriptions at randomly selected Dunedin city pharmacies. Of 135 subjects whose histories, and lung function data where available, were consistent with asthma, 20 did not know they had asthma. Only half could give a simple explanation of asthma, and many were confused about therapies, especially the use of corticosteroids. Only half demonstrated satisfactory aerosol inhalation technique. Deficiencies in medical management including lack of lung function monitoring, regular followup and provision of a crisis plan for severe attacks were noted. Patients previously hospitalised more often had a crisis plan and recalled advice on management of asthma, but had little knowledge about the nature of the condition. The continuing high asthma mortality rate in New Zealand may in part reflect management deficiencies both in long term care and in recognition and management of severe attacks. These may be compounded by poor patient understanding of asthma.

摘要

通过由访谈者管理的问卷,对在达尼丁市随机选择的药店中通过处方识别出的社区哮喘患者样本进行调查,以评估患者对哮喘本质及其管理的理解。在135名病史和(如有)肺功能数据与哮喘相符的受试者中,20人不知道自己患有哮喘。只有一半的人能够对哮喘做出简单解释,许多人对治疗方法感到困惑,尤其是皮质类固醇的使用。只有一半的人展示了令人满意的气雾剂吸入技术。注意到在医疗管理方面存在不足,包括缺乏肺功能监测、定期随访以及为严重发作提供危机处理计划。以前住院次数较多的患者有危机处理计划,并且记得有关哮喘管理的建议,但对病情的本质了解甚少。新西兰持续较高的哮喘死亡率可能部分反映了长期护理以及严重发作的识别和管理方面的管理不足。患者对哮喘的理解不足可能会使这些情况更加复杂。

相似文献

1
How well do New Zealand patients understand and manage their asthma? A community study.新西兰患者对其哮喘的了解和管理情况如何?一项社区研究。
N Z Med J. 1987 Nov 11;100(835):674-7.
2
Asthma management in general practice.全科医疗中的哮喘管理
Aust Fam Physician. 1991 Aug;20(8):1085, 1088-9, 1092.
3
[The quality of asthma treatment in Denmark. How far are we--and how far are our patients?].[丹麦哮喘治疗的质量。我们做到了什么程度——我们的患者又做到了什么程度?]
Ugeskr Laeger. 2008 Jan 21;170(4):230-4.
4
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).孟鲁司特或沙美特罗联合吸入性糖皮质激素治疗成人哮喘:一项随机、双盲对照研究的设计与原理(孟鲁司特作为辅助治疗药物的IMPACT研究)
Respir Med. 2000 Jun;94(6):612-21. doi: 10.1053/rmed.2000.0806.
5
Evidence-based asthma management.基于证据的哮喘管理。
Respir Care. 2004 Jul;49(7):783-92.
6
Asthma control in a random sample of New Zealand adolescent asthmatics.新西兰青少年哮喘患者随机样本中的哮喘控制情况。
J Asthma. 2007 May;44(4):261-6. doi: 10.1080/02770900701246873.
7
Successful treatment of previously uncontrolled adult asthma with budesonide inhalation suspension: five-year case histories.布地奈德吸入混悬液成功治疗既往未控制的成人哮喘:五年病例史
Ann Pharmacother. 2007 Oct;41(10):1728-33. doi: 10.1345/aph.1K133. Epub 2007 Aug 14.
8
Lessons from the national asthma mortality study: circumstances surrounding death.
N Z Med J. 1987 Jan 28;100(816):10-3.
9
Effects of an asthma management program on the asthmatic member: patient-centered results of a 2-year study in a managed care organization.哮喘管理项目对哮喘患者的影响:在一家管理式医疗组织中进行的为期两年研究的以患者为中心的结果
Am J Manag Care. 1998 Sep;4(9):1288-97.
10
[Round Table: Severe asthma in pediatrics: treatment of acute crises].[圆桌会议:儿科重症哮喘:急性发作的治疗]
Allergol Immunopathol (Madr). 1999 Mar-Apr;27(2):53-62.